Filing Details
- Accession Number:
- 0000904454-16-000823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-05 17:51:05
- Reporting Period:
- 2016-01-04
- Filing Date:
- 2016-01-05
- Accepted Time:
- 2016-01-05 17:51:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1314102 | Psivida Corp. | PSDV | Laboratory Analytical Instruments (3826) | 262774444 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458753 | S Leonard Ross | C/O Psivida Corp. 480 Pleasant Street Watertown MA 02472 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-01-04 | 5,000 | $1.81 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-01-04 | 5,000 | $4.70 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-01-04 | 5,000 | $0.00 | 5,000 | $1.81 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2019-06-25 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.
- The option was granted on 06/25/2009 and vested in four equal annual installments beginning on the first anniversary of the date of grant.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.74. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.